Pancreatic Cancer Research

ResearcherLankenau Institute for Medical ResearchNo recent work listed

Masaya Jimbo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3181-3683; OpenAlex author ID A5078078975. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
34
Papers, trials and grants by year

2014: 2 papers · 2015: 2 papers · 2016: 2 papers · 2017: 1 paper · 2018: 1 paper

Papers 8

  1. Cytoplasmic HuR Status Predicts Disease-free Survival in Resected Pancreatic Cancer: A Post-hoc Analysis From the International Phase III ESPAC-3 Clinical Tria… Co-author DOI 10.1097/sla.0000000000002088↗
  2. Posttranscriptional Upregulation of IDH1 by HuR Establishes a Powerful Survival Phenotype in Pancreatic Cancer Cells. Co-author DOI 10.1158/0008-5472.can-17-0015↗
  3. GPRC5A is a potential oncogene in pancreatic ductal adenocarcinoma cells that is upregulated by gemcitabine with help from HuR. Co-author DOI 10.1038/cddis.2016.169↗
  4. The mRNA-binding protein HuR promotes hypoxia-induced chemoresistance through posttranscriptional regulation of the proto-oncogene PIM1 in pancreatic cancer ce… First author DOI 10.1038/onc.2015.325↗
  5. MUC1 Promoter-Driven DTA as a Targeted Therapeutic Strategy against Pancreatic Cancer. Co-author DOI 10.1158/1541-7786.mcr-14-0199↗
  6. Targeting the mRNA-binding protein HuR impairs malignant characteristics of pancreatic ductal adenocarcinoma cells. Co-author DOI 10.18632/oncotarget.4743↗
  7. HuR posttranscriptionally regulates WEE1: implications for the DNA damage response in pancreatic cancer cells. Co-author DOI 10.1158/0008-5472.can-13-1915↗
  8. dCK expression correlates with 5-fluorouracil efficacy and HuR cytoplasmic expression in pancreatic cancer: a dual-institutional follow-up with the RTOG 9704 t… Co-author DOI 10.4161/cbt.28413↗

Closest collaborators

The 25 strongest of 34 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jonathan Robert Brody · 8 shared papers, 2014–2018 · strength 0.38
  2. Jordan Michael Winter · 7 shared papers, 2014–2018 · strength 0.32
  3. Charles J. Yeo · 7 shared papers, 2014–2018 · strength 0.32
  4. Fernando F. Blanco · 5 shared papers, 2015–2017 · strength 0.24
  5. Shruti Lal · 4 shared papers, 2014–2017 · strength 0.17
  6. Isidore Rigoutsos · 3 shared papers, 2014–2016 · strength 0.14
  7. Agnieszka Katarzyna Witkiewicz · 3 shared papers, 2014–2016 · strength 0.12
  8. Wei Jiang · 2 shared papers, 2016–2018 · strength 0.11
  9. Richard Andrew Burkhart · 3 shared papers, 2014–2015 · strength 0.11
  10. Christine A. Iacobuzio–Donahue · 2 shared papers, 2014–2015 · strength 0.08
  11. Talar Tatarian · 1 shared paper, 2018 · strength 0.07
  12. Paula Ghaneh · 1 shared paper, 2018 · strength 0.07
  13. Markus Wolfgang Büchler · 1 shared paper, 2018 · strength 0.07
  14. Daniel H. Palmer · 1 shared paper, 2018 · strength 0.07
  15. John P. Neoptolemos · 1 shared paper, 2018 · strength 0.07
  16. William Greenhalf · 1 shared paper, 2018 · strength 0.07
  17. Christopher Michael Halloran · 1 shared paper, 2018 · strength 0.07
  18. Eithne Costello · 1 shared paper, 2018 · strength 0.07
  19. H Zhou · 1 shared paper, 2016 · strength 0.06
  20. Saswati N. Chand · 1 shared paper, 2017 · strength 0.05
  21. Seth J. Parker · 1 shared paper, 2017 · strength 0.05
  22. Mahsa Zarei · 1 shared paper, 2017 · strength 0.05
  23. Ali Vaziri Gohar · 1 shared paper, 2017 · strength 0.05
  24. Christian M. Metallo · 1 shared paper, 2017 · strength 0.05
  25. Avinoam Nevler · 1 shared paper, 2017 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.